Date: November 16, 2026

ESOP Allotment Details

Gland Pharma Limited's ESOP Compensation Committee approved the allotment of 3,739 equity shares of face value ₹1 each to 2 employees upon exercise of stock options under the Gland Pharma Employee Stock Options Scheme, 2025. The committee meeting was held on November 16, 2026.

Share Capital Impact

The allotment increases the company's issued, subscribed, and paid-up share capital to ₹165,014,593, comprising 165,014,593 equity shares of face value ₹1 each.

Exercise Price and Premium Details

The 3,739 options were exercised at two different prices:

  • 2,474 options at ₹773.30 each with a premium of ₹772.30 per share
  • 1,265 options at ₹1 each with no premium

Share Characteristics

  • The new shares rank pari passu with existing shares
  • Shares were issued in dematerialized form with ISIN INE068V01023
  • Distinctive numbers range from 16,50,10,855 to 16,50,14,593 (both inclusive)
  • No lock-in restrictions apply to these shares

Not Applicable Sections

No material disclosures under the following sections: KMP / Board / Auditor Changes, Dividend Declaration, Financial Results, Auditor's Report, Disinvestment / Strategic Actions, Media Release / Investor Communication.